Inviga Healthcare Fund (IHF) recently acquired a significant 21 percent stake in Forus Health Pvt. Ltd., a Bengaluru-based ophthalmic diagnostics company. This strategic investment highlights the growing commitment to advanced AI eye screening solutions within India’s healthcare sector. Forus Health is widely recognized for its innovative, AI-driven eye screening technologies. Its devices have successfully screened over 22 million patients across more than 75 countries, consequently delivering crucial last-mile comprehensive eye diagnostics to over five million individuals globally through an integrated digital platform.
The secondary transaction marks Inviga’s second major investment, following its stake in vaccine developer Mynvax in 2024. Furthermore, it underscores the fund’s clear intention to back technology-led, scalable healthcare ventures built in India for global markets. Dr. B. S. Ajaikumar, Chairman of HealthCare Global Enterprises (HCG) and founder of IHF, affirmed, “Forus Health embodies the Inviga ethos — clinically strong, technologically deep, socially impactful and growth-oriented.” He added that this investment truly signifies confidence in India’s capacity to produce world-class healthcare innovations for both domestic and international markets.
Driving Innovation with AI Eye Screening
The partnership aims to expand Forus Health’s med-tech franchise and advance accessible solutions for preventable blindness. K. Chandrasekhar, Co-founder and CEO of Forus Health, stated that the investment arrives at a pivotal time for the company’s expansion. “We are thrilled to welcome Inviga as we expand our AI and platform capabilities and strengthen our global presence. Our mission remains focused on eradicating preventable blindness,” he emphasized. Inviga Fund Manager Rakshith Rangarajan noted that Forus Health’s “Make in India, Make for India and Make for the World” philosophy deeply resonates with the fund’s objectives, confidently predicting sustained growth and long-term value creation through this collaboration.
Moreover, AI is actively transforming eye care in India, offering considerable hope for early detection and effective management of various eye diseases. For example, AI-powered screening camps have diagnosed conditions like diabetic retinopathy and cataracts early in rural areas. Indian startups are also developing AI tools for cost-effective retinal imaging and disease detection, thereby bridging gaps in access and accuracy. Google Research, in collaboration with partners like Aravind Eye Hospital in India, has also explored how AI can reduce preventable blindness, particularly for diabetic retinopathy. For medical professionals interested in understanding these advancements, a Certification Course In Ophthalmology could provide valuable insights into modern diagnostic techniques.
Addressing the Global Burden of Preventable Blindness
Globally, over 2.2 billion people suffer from vision impairment or blindness, with nearly half of these cases being avoidable. Similarly, more than 270 million Indians live with some form of visual impairment, and most cases are preventable through early detection. Therefore, AI-enabled systems are crucial for public health. These systems can screen large populations efficiently, process high-resolution retinal images for early signs of diseases, and deliver instant diagnoses, consequently allowing for quicker treatment decisions.
Inviga Healthcare Fund employs a dual investment strategy. It develops multi-specialty hospital platforms while simultaneously investing in emerging healthcare and life sciences companies. This approach aims to foster scalable innovation and create long-term impact across India’s healthcare ecosystem.
Frequently Asked Questions
Q1: What is Inviga Healthcare Fund’s primary objective with this investment?
Inviga Healthcare Fund aims to support technology-led, scalable healthcare ventures built in India for global markets, believing that Forus Health’s AI-driven solutions align perfectly with its ethos of clinically strong, technologically deep, and socially impactful innovation.
Q2: How does Forus Health contribute to combating preventable blindness?
Forus Health develops AI-driven ophthalmic diagnostic devices that have screened over 22 million patients across 75+ countries, providing comprehensive eye diagnostics, especially for last-mile populations, and working towards eradicating preventable blindness.
Q3: Why is AI eye screening significant for India?
India faces a high burden of visual impairment, with many cases being preventable through early detection. AI eye screening offers scalable, accurate, and cost-effective solutions for identifying eye diseases early, improving accessibility to quality eye care, particularly in remote areas.
References
- Inviga Healthcare Fund picks up 21% stake in Forus Health – ETHealthworld
- The Role of AI in Early Detection of Eye Diseases in India – Laxmi Eye Hospital
- How AI is making eyesight-saving care more accessible in resource-constrained settings
- Revolutionizing Vision – How Artificial Intelligence is Transforming Eye Care in India
- Forus Health | Innovative Eye Care Solutions & Teleophthalmology
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.